Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus isotretinoin for acne treatment
IRCT20140624018210N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of metformin and isotretinoin in acne vulgaris (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Change in acne severity. Started May 2018; status: completed.
02
Drugs
metforminisotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20140624018210N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140624018210N8.